HR+ Breast Cancer – Hormone receptor-positive breast cancer is a type of breast cancer that grows in response to hormones like estrogen or progesterone. It is characterized by the presence of receptors for these hormones on the surface of the cancer cells. This type of cancer tends to grow more slowly than hormone receptor-negative cancers. It can occur at any age but is more common in postmenopausal women. The progression of the disease can vary, with some cases remaining localized while others may spread to other parts of the body.
CCNE1 Amplification – CCNE1 amplification refers to an increase in the number of copies of the CCNE1 gene, which can lead to uncontrolled cell division and cancer progression. This genetic alteration is often associated with aggressive tumor behavior and poor prognosis. It is commonly observed in various types of cancers, including ovarian and breast cancers. The amplification can contribute to resistance to certain cancer treatments. The progression of cancers with CCNE1 amplification can be rapid and challenging to manage.
HER2-negative Breast Cancer – HER2-negative breast cancer is a type of breast cancer that tests negative for the human epidermal growth factor receptor 2 (HER2) protein. This means the cancer cells do not have an excess of the HER2 protein on their surfaces. HER2-negative cancers can be either hormone receptor-positive or triple-negative, affecting treatment options and disease progression. These cancers may grow at different rates and can spread to other parts of the body. The absence of HER2 overexpression influences the choice of targeted therapies.
Advanced Solid Tumor – Advanced solid tumors refer to cancers that have progressed to a late stage, often spreading beyond their original site to other parts of the body. These tumors can arise in various organs and tissues, including the lungs, liver, and pancreas. The progression of advanced solid tumors can be aggressive, with symptoms depending on the location and size of the tumor. They often require complex treatment strategies due to their advanced nature. The growth and spread of these tumors can significantly impact the patient’s quality of life.
Ovarian Cancer – Ovarian cancer originates in the ovaries and is often detected at an advanced stage due to subtle early symptoms. It can spread to the pelvis and abdomen, making it more challenging to treat. The disease is characterized by the uncontrolled growth of cells in the ovaries, which can form tumors. Ovarian cancer can progress rapidly, affecting nearby organs and tissues. The progression and symptoms can vary, with some cases remaining localized while others metastasize.
Endometrial Cancer – Endometrial cancer begins in the lining of the uterus, known as the endometrium. It is the most common type of uterine cancer and often presents with symptoms like abnormal vaginal bleeding. The disease typically progresses slowly, but some aggressive forms can spread to other parts of the body. Risk factors include obesity, hormone imbalances, and certain genetic conditions. The progression of endometrial cancer can vary, with early detection often leading to better outcomes.
Gastric Cancer – Gastric cancer, also known as stomach cancer, develops from the lining of the stomach. It can spread to nearby organs and lymph nodes, often leading to symptoms like indigestion and stomach pain. The progression of gastric cancer can be slow or rapid, depending on the type and stage of the disease. Risk factors include diet, smoking, and certain infections. The disease can significantly impact digestion and overall health as it advances.
Belgium 
France 
Italy 
Spain 
